Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Nora AI
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Redeye: Dignitana Q4’22 - Underlying positive momentum

Dignitana

Redeyes’ view on Dignitana is generally unchanged. We see that the sales momentum continued in the quarter, which could have been even higher without the component issues that hampered sales a bit. A write-down negatively affected the gross margin; however, the underlying gross margin was in the normal range. The US market is transforming, and we believe there is more to come which supports the long-term growth case in Dignitana. The development over quarters can vary, but the trend is positive. We lower our very high expectation on growth for 2023e to high. With the estimate adjustments, we adjust our fair value range to SEK 5 (7) to SEK 22 (24) per share and a Base case value of SEK 12 (15) per share.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments


Dignitana Q4’22 - Underlying positive momentum

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.